J&J Subsidiary Slammed With $80M Verdict

Introduction

On Friday, May 17, a Philadelphia jury awarded $80 million in a pelvic mesh verdict to plaintiffs over alleged damages against Johnson & Johnson subsidiary Ethicon.

According to the plaintiffs’ attorney, a woman had the mesh implanted in 2008 to treat her organ prolapse, but the product gradually had worn away leaving her with significant infections, inflammation, and pain that required several revision surgeries. The Philadelphia Court of Common Pleas Judge Daniel Anders granted $80.025 million to the woman and her husband of Media, Pennsylvania, which also included $50 million in punitive damages.

Ethicon pelvic mesh lawsuits are consolidated as a part of multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) before U.S. District Judge Joseph R. Goodwin in the Southern District of West Virginia.

Comments

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

J&J Subsidiary Slammed With $80M Verdict